Prognostic significance of febrile episodes in lung cancer patients receiving chemotherapy

Supportive Care in Cancer

Volumn 6, Issue 4, 1998, Pages 396-401

  Rikimaru, Toru ^a   Ichiki, Masao ^a   Ookubo, Yo ^a   Matumoto, Kumi ^a   Mimori, Yoshiko ^a   Sueyasu, Yoshiko ^a   Kinoshita, Masaharu ^a   Yano, Hideki ^a   Shiraishi, Tsuneaki ^a   Oizumi, Kotaro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Febrile episode; Infection; Lung cancer; Neutropenia; Prognostic factors

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; INCIDENCE; INFECTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPENIA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 7344243727     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050183     Document Type: Article

References (17)

1. Miller B, Ries LAG, Hankey BF, Kosary CL, Edwards BK (1992) Cancer statistics review: 1973-89. (NIH publication 92-2789) National Cancer Institute, Bethesda
2. Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55:891-903
3. Inagi J, Rodriguez V, Bodey GB (1974) Causes of death in cancer patients. Cancer 33:568-573
4. Uh S, Lee SM, Kim HT, Chung Y, Kim YH, Park C, Huh SJ, Lee HB (1994) The effect of radiation therapy on immune function in patients with squamous cell carcinoma. Chest 105:133-137
5. Pizzo PA (1993) Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323-1332
6. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
7. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
8. Cox DR (1972) Regression models and life tables. J R Stat Soc 34:163-170
9. Bodey GB, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340
10. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12:1272-1280
11. Johnson BE, Steinberg SM, Phelps R, Edison M, Veach SR, Ihde DC (1988) Female patients with small cell lung cancer live longer than male patients. Am J Med 85:194-196
12. Ries LAG (1994) Influence of extent disease, histology, and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 10:21-30
13. De Repentigny L, Reiss E (1984) Current tends in immunodiagnosis of candidasis and aspergillosis. Rev Infect Dis 3:301-312
14. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stwart M, Glaspy J (1991) Reduction by granulocytes colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164-170
15. Trillet Lenoir V, Green J, Manegold C, Von Pawel J, Gatzemeier U, Lebeau B, Depierre A, Johnson P, Tomota D (1993) Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 29:319-324
16. Fausto de Lalla (1997) Antibiotic treatment of febrile episodes in neutropenic cancer patients. Drugs 5:789-804
17. Rossini F, Pioltelli P, Mingozzi S, Bregani R, Bolis S, Casaroli I, Lanzi E, Pogliani EM, Corneo G (1994) Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors. Support Care Cancer 2:259-265